Share Email Print

Proceedings Paper

Enhanced antitumoral efficacy by intratumoral perfusion of activated macrophages associated with photodynamic therapy
Author(s): Vasile F. Dima; Virgil V. Vasiliu; Dezideriu Laky; Paul Ionescu; Stefan V. Dima
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Experiments were performed on five batches of Wistar inbred rats with Walker-256 carcinosarcoma receiving photodynamic therapy (PDT), rMuIFN-gamma activated macrophages (AM(Phi) ) or associated therapy (PDT-AM(Phi) -A; PDT-AM(Phi) -B); the control batch (HBSS) consisted of animals with untreated Walker-256 tumors. The results were as follows: the sole treatment (PDT, AM(Phi) ) gave survival rates between 57.2 and 57.7% and cure rates ranging from 23.1 to 34.3%. The 'combined' therapy in multiple doses increased significantly (87.9%) the survival rate of tumor bearing rats as well as the rate of complete tumor regression (72.7%). Cell-mediated immunity test values in batches III and IV exposed to multiple doses of PDT-AM(Phi) showed higher values as compared to the values noticed in batches I - II and the control batch V, performed at 12 and 21 days post-treatment. Summing up, these results demonstrate that 'combined' photodynamic treatment and biotherapy with interferon activated macrophages stimulate cell-mediated antitumoral activity, increase survival rates and reduce incidence of Walker-256 carcinosarcoma in rat model.

Paper Details

Date Published: 31 January 1996
PDF: 11 pages
Proc. SPIE 2625, Photochemotherapy: Photodynamic Therapy and Other Modalities, (31 January 1996); doi: 10.1117/12.230987
Show Author Affiliations
Vasile F. Dima, Cantacuzino Institute (Romania)
Virgil V. Vasiliu, Institute of Atomic Physics (Romania)
Dezideriu Laky, Victor Babes Institute (Romania)
Paul Ionescu, Central Military Hospital (Romania)
Stefan V. Dima, Cantacuzino Institute (Romania)

Published in SPIE Proceedings Vol. 2625:
Photochemotherapy: Photodynamic Therapy and Other Modalities
Benjamin Ehrenberg; Giulio Jori; Johan Moan, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?